Dmitry Kulish: This is an important question because Brussels politicians are speculating on this topic. They say they can't trust a vaccine that it isn't trusted by the people of Russia. The answer to this question is twofold. First, it's not correct to say that the decision was made to export the majority of local production. The decision was made to localize the production of Sputnik all around the world. 4 key manufacturers (Argentina, India, Brazil, Korea) promised to produce 1 billion dosages per year. Therefore, I would disagree that we decided to export a local production: we decided to spread the vaccine instead. This is what Pfizer didn't do at the very beginning, and today, when President Biden is called to restrict intellectual property rights to Pfizer, they try to make a procedure that was done already for Sputnik. Russian local production will stay at around 150 million dosages per year to cover local demand.
The second level is a problem of trust in relation to vaccines. In Russia, we have very dramatic circumstances of manipulative European and American propaganda against Sputnik V vaccine that occurred during last August-September. For me as a scientist, who lived in the US for 10 years, it is a personal tragedy: I was reading the newspapers I've loved for all my life (such as Science magazine or National Geographic, etc.) and looking at the manipulative propaganda on why the Sputnik vaccine is bad. The numbers are hard to define, but some people say only about 50% or even 30% of Russians are ready to vaccinate. We do have progress, but still, it's a low number. Therefore, honestly, when we decide to export, it's not a topic of politics, but a topic of the supply-demand market economy. As soon as we have a higher demand in Russia, we will immediately satisfy it with local production.